Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Isolation, Behavioral Changes, and Low Seroprevalence of SARS-CoV-2 Antibodies in Patients With Systemic Lupus Erythematosus or Rheumatoid Arthritis.
Ammitzbøll C, Andersen JB, Vils SR, Mistegaard CE, Mikkelsen S, Erikstrup C, Thomsen MK, Hauge EM, Troldborg A. Ammitzbøll C, et al. Among authors: troldborg a. Arthritis Care Res (Hoboken). 2022 Nov;74(11):1780-1785. doi: 10.1002/acr.24716. Epub 2022 Aug 4. Arthritis Care Res (Hoboken). 2022. PMID: 34057311 Free PMC article.
Impaired Antibody Response to the BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine in Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis.
Ammitzbøll C, Bartels LE, Bøgh Andersen J, Risbøl Vils S, Elbaek Mistegård C, Dahl Johannsen A, From Hermansen ML, Kragh Thomsen M, Erikstrup C, Hauge EM, Troldborg A. Ammitzbøll C, et al. Among authors: troldborg a. ACR Open Rheumatol. 2021 Sep;3(9):622-628. doi: 10.1002/acr2.11299. Epub 2021 Jul 17. ACR Open Rheumatol. 2021. PMID: 34273260 Free PMC article.
Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis.
Bartels LE, Ammitzbøll C, Andersen JB, Vils SR, Mistegaard CE, Johannsen AD, Hermansen MF, Thomsen MK, Erikstrup C, Hauge EM, Troldborg A. Bartels LE, et al. Among authors: troldborg a. Rheumatol Int. 2021 Nov;41(11):1925-1931. doi: 10.1007/s00296-021-04972-7. Epub 2021 Sep 2. Rheumatol Int. 2021. PMID: 34476603 Free PMC article.
Established risk loci for systemic lupus erythematosus at NCF2, STAT4, TNPO3, IRF5 and ITGAM associate with distinct clinical manifestations: A Danish genome-wide association study.
Leffers HCB, Westergaard D, Saevarsdottir S, Jonsdottir I, Pedersen OB; DBDS genomic consortium; Troldborg A, Voss A, Kristensen S, Lindhardsen J, Kumar P, Linauskas A, Juul L, Krogh NS, Deleuran B, Dreyer L, Schwinn M, Thørner LW, Hindhede L, Erikstrup C, Ullum H, Brunak S, Stefansson K, Banasik K, Jacobsen S. Leffers HCB, et al. Among authors: troldborg a. Joint Bone Spine. 2022 Jul;89(4):105357. doi: 10.1016/j.jbspin.2022.105357. Epub 2022 Feb 12. Joint Bone Spine. 2022. PMID: 35167971 No abstract available.
COVID-19 vaccination in patients with rheumatic diseases leads to a high seroconversion rate and reduced self-imposed isolation and shielding behaviour.
Ammitzbøll C, Thomsen MK, Andersen JB, Bartels LE, Hermansen MF, Johannsen AD, Mistegaard CE, Mikkelsen S, Vils SR, Erikstrup C, Hauge EM, Troldborg A. Ammitzbøll C, et al. Among authors: troldborg a. Mod Rheumatol. 2023 Jul 4;33(4):777-785. doi: 10.1093/mr/roac069. Mod Rheumatol. 2023. PMID: 35860843 Free PMC article.
Rituximab-treated rheumatic patients: B cells predict seroconversion after COVID-19 boost or revaccination in initial vaccine non-responders.
Ammitzbøll C, Kragh Thomsen M, Bøgh Andersen J, Jensen JMB, From Hermansen ML, Dahl Johannsen A, Larsen ML, Mistegaard CE, Mikkelsen S, Szabados F, Vils SR, Erikstrup C, Hauge EM, Troldborg A. Ammitzbøll C, et al. Among authors: troldborg a. Rheumatology (Oxford). 2023 Jul 5;62(7):2544-2549. doi: 10.1093/rheumatology/keac666. Rheumatology (Oxford). 2023. PMID: 36445008
69 results